Goodrx Holdings Net Worth
Goodrx Holdings Net Worth Breakdown | GDRX |
Goodrx Holdings Net Worth Analysis
Goodrx Holdings' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Goodrx Holdings' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Goodrx Holdings' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Goodrx Holdings' net worth analysis. One common approach is to calculate Goodrx Holdings' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Goodrx Holdings' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Goodrx Holdings' net worth. This approach calculates the present value of Goodrx Holdings' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Goodrx Holdings' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Goodrx Holdings' net worth. This involves comparing Goodrx Holdings' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Goodrx Holdings' net worth relative to its peers.
To determine if Goodrx Holdings is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Goodrx Holdings' net worth research are outlined below:
| Goodrx Holdings generated a negative expected return over the last 90 days | |
| Goodrx Holdings has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 750.26 M. Net Loss for the year was (8.87 M) with profit before overhead, payroll, taxes, and interest of 701.48 M. | |
| Goodrx Holdings has a strong financial position based on the latest SEC filings | |
| About 71.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Barclays Cuts GoodRx Price Target to 6.00 |
Goodrx Holdings Quarterly Good Will |
|
Goodrx Holdings uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Goodrx Holdings. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Goodrx Holdings' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Goodrx Holdings' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Goodrx Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Goodrx Holdings backward and forwards among themselves. Goodrx Holdings' institutional investor refers to the entity that pools money to purchase Goodrx Holdings' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Rip Road Capital Partners Lp | 2024-06-30 | 2.2 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2 M | Blackrock Inc | 2024-06-30 | 1.7 M | Technology Crossover Management X, Ltd. | 2024-09-30 | 1.7 M | Point72 Asset Management, L.p. | 2024-09-30 | 1.6 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.6 M | State Street Corp | 2024-06-30 | 1.1 M | Connor Clark & Lunn Inv Mgmt Ltd | 2024-06-30 | 1 M | Geode Capital Management, Llc | 2024-09-30 | 982.7 K | Francisco Partners Management Lp | 2024-09-30 | 70.1 M | Vanguard Group Inc | 2024-09-30 | 7.9 M |
Follow Goodrx Holdings' market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.87 B.Market Cap |
|
Project Goodrx Holdings' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
When accessing Goodrx Holdings' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Goodrx Holdings' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Goodrx Holdings' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Goodrx Holdings' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Goodrx Holdings. Check Goodrx Holdings' Beneish M Score to see the likelihood of Goodrx Holdings' management manipulating its earnings.
Evaluate Goodrx Holdings' management efficiency
Goodrx Holdings has return on total asset (ROA) of 0.0421 % which means that it generated a profit of $0.0421 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0206) %, meaning that it created substantial loss on money invested by shareholders. Goodrx Holdings' management efficiency ratios could be used to measure how well Goodrx Holdings manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.0082 in 2024. Return On Capital Employed is likely to rise to -0.02 in 2024. At this time, Goodrx Holdings' Net Tangible Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 23.9 M in 2024, whereas Total Assets are likely to drop slightly above 1.3 B in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.86 | 1.95 | |
| Tangible Book Value Per Share | 0.47 | 0.50 | |
| Enterprise Value Over EBITDA | 25.62 | 24.34 | |
| Price Book Value Ratio | 3.61 | 3.43 | |
| Enterprise Value Multiple | 25.62 | 24.34 | |
| Price Fair Value | 3.61 | 3.43 | |
| Enterprise Value | 14 B | 12.4 B |
The strategic initiatives led by Goodrx Holdings' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue 2.5157 | Revenue 790.4 M | Quarterly Revenue Growth 0.085 | Revenue Per Share 2.027 | Return On Equity (0.02) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Goodrx Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on Goodrx Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Goodrx Holdings insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Goodrx Holdings Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 18th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 10th of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Goodrx Holdings Earnings per Share Projection vs Actual
Goodrx Holdings Corporate Management
| Douglas Hirsch | CoCEO Cofounder | Profile | |
| Andrew Slutsky | Chief Officer | Profile | |
| Nitin Shingate | Chief Officer | Profile | |
| Babak Azad | Chief Communications | Profile | |
| Whitney Notaro | Vice Relations | Profile |
Additional Tools for Goodrx Stock Analysis
When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.